Shares of ICU Medical, Incorporated (NASDAQ:ICUI) have been given a consensus recommendation of “Hold” by the six research firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has issued a buy recommendation on the company.

Several research analysts have recently weighed in on the stock. KeyCorp assumed coverage on shares of ICU Medical, in a research note on Tuesday. They set a “sector weight” rating on the stock. Zacks Investment Research upgraded shares of ICU Medical, from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. BidaskClub lowered shares of ICU Medical, from a “hold” rating to a “sell” rating in a research note on Thursday, August 24th. Finally, Gabelli restated a “buy” rating on shares of ICU Medical, in a research note on Friday, August 11th.

ICU Medical, (ICUI) traded up 0.32% during trading on Tuesday, reaching $189.00. 6,444 shares of the company’s stock traded hands. The firm has a 50 day moving average price of $182.29 and a 200-day moving average price of $168.75. The firm has a market cap of $3.75 billion, a PE ratio of 75.69 and a beta of 0.35. ICU Medical, has a 12 month low of $127.00 and a 12 month high of $192.65.

ICU Medical, (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by ($0.06). ICU Medical, had a negative net margin of 11.18% and a negative return on equity of 13.14%. The business had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. During the same quarter in the previous year, the firm posted $1.15 earnings per share. The firm’s quarterly revenue was up 242.8% on a year-over-year basis. On average, analysts forecast that ICU Medical, will post $4.11 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/10/17/icu-medical-incorporated-icui-given-consensus-rating-of-hold-by-analysts.html.

In other news, Director Robert S. Swinney sold 463 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $181.25, for a total transaction of $83,918.75. Following the transaction, the director now directly owns 14,330 shares in the company, valued at approximately $2,597,312.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 1,784 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $174.47, for a total transaction of $311,254.48. Following the transaction, the vice president now owns 102 shares in the company, valued at $17,795.94. The disclosure for this sale can be found here. Insiders have sold a total of 26,929 shares of company stock worth $4,911,313 over the last 90 days. 13.60% of the stock is owned by company insiders.

Several institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. increased its stake in shares of ICU Medical, by 0.6% during the 2nd quarter. BlackRock Inc. now owns 1,780,976 shares of the medical instruments supplier’s stock worth $307,218,000 after purchasing an additional 11,046 shares during the last quarter. Janus Capital Management LLC grew its stake in ICU Medical, by 178.8% in the 1st quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock valued at $219,864,000 after buying an additional 923,395 shares during the last quarter. Janus Henderson Group PLC acquired a new position in ICU Medical, in the 2nd quarter valued at about $247,072,000. Vanguard Group Inc. grew its stake in ICU Medical, by 16.3% in the 2nd quarter. Vanguard Group Inc. now owns 1,304,282 shares of the medical instruments supplier’s stock valued at $224,989,000 after buying an additional 183,133 shares during the last quarter. Finally, Wells Fargo & Company MN grew its stake in ICU Medical, by 19.3% in the 2nd quarter. Wells Fargo & Company MN now owns 555,712 shares of the medical instruments supplier’s stock valued at $95,861,000 after buying an additional 89,872 shares during the last quarter. Institutional investors own 78.13% of the company’s stock.

About ICU Medical,

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Receive News & Ratings for ICU Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.